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Abstract. 
 
We have developed a permeabilized cell as-
say to study the nuclear export of the shuttling tran-
scription factor NFAT, which contains a leucine-rich 
export signal. The assay uses HeLa cells that are stably 
transfected with NFAT fused to the green fluorescent 
protein (GFP). Nuclear export of GFP–NFAT in digi-
tonin-permeabilized cells occurs in a temperature- and 
ATP-dependent manner and can be quantified by flow 
cytometry. In vitro NFAT export requires the GTPase 
Ran, which is released from cells during the digitonin 
permeabilization. At least one additional rate-limiting 
export factor is depleted from permeabilized cells by a 
 
preincubation at 30
 
8
 
C in the absence of cytosol. This ac-
tivity can be provided by cytosolic or nucleoplasmic ex-
tracts in a subsequent export step. Using this assay, we 
have purified a second major export activity from cyto-
sol. We found that it corresponds to CRM1, a protein 
recently reported to be a receptor for certain leucine-
rich export sequences. CRM1 appears to be imported 
into the nucleus by a Ran-dependent mechanism that is 
distinct from conventional signaling pathways. Consid-
ered together, our studies directly demonstrate by frac-
tionation and reconstitution that nuclear export of 
NFAT is mediated by multiple nucleocytoplasmic shut-
tling factors, including Ran and CRM1.
 
N
 
ucleocytoplasmic
 
 trafficking is mediated by nu-
clear pore complexes (NPCs)
 
1
 
, large supramolec-
ular structures that span the nuclear envelope
(for reviews see Doye and Hurt, 1997; Nigg, 1997). Mol-
ecules smaller than 
 
z
 
20–40 kD can passively diffuse
through aqueous channels in the NPC. In contrast, most
macromolecules traverse the NPC by energy-, tempera-
ture-, and signal-dependent mechanisms. The best charac-
terized signals for nuclear import (nuclear localization
sequences [NLSs]) are short stretches of amino acids en-
riched in basic residues that occur as either a single or a bi-
partite motif (for review see Dingwall and Laskey, 1991).
The M9 domain of the hnRNP A1 protein contains a qual-
itatively distinct type of NLS, a 38-amino acid stretch that
is enriched in aromatic and glycine residues (Siomi and
Dreyfuss, 1995).
The nuclear import of proteins containing basic amino
acid-rich (classical) NLSs is beginning to be characterized
in molecular detail (for review see Görlich and Mattaj,
1996; Nigg, 1997). Studies with a transport assay using dig-
itonin-permeabilized cells (Adam et al., 1990) have identi-
fied four conserved soluble factors directly involved in
the nuclear import of proteins with classic NLSs: (
 
a
 
) im-
portin 
 
a
 
/karyopherin 
 
a
 
/NLS receptor/Srp1
 
a
 
, (
 
b
 
) importin
 
b
 
/karyopherin 
 
b
 
/p97, (
 
c
 
) the small GTPase Ran/TC4, and
(
 
d
 
) NTF2/p10 (for reviews see Görlich and Mattaj, 1996;
Nigg, 1997). Nuclear import appears to involve the step-
wise movement of a complex containing the transport sub-
strate, importin 
 
a
 
, and importin 
 
b
 
 through the NPC (Nigg,
1997). Translocation through the NPC also requires RanGTP
hydrolysis (Melchior et al., 1993; Moore and Blobel, 1993;
Schlenstedt et al., 1995; Mahajan et al., 1997) and NTF2
(Moore and Blobel, 1994; Paschal and Gerace, 1995), but
the exact functions of these components are not resolved.
Nuclear import mediated by the M9 domain of hnRNP A1
involves a receptor called transportin (Pollard et al., 1996)
that is distantly related to importin 
 
b
 
, and also is suggested
to involve Ran (Bonifaci et al., 1997; Izaurralde et al., 1997).
In comparison to nuclear protein import, considerably
less is known about the mechanisms of nuclear export of
proteins and RNA–protein complexes (for review see Iza-
urralde and Mattaj, 1995; Görlich and Mattaj, 1996). An
important advance was the characterization of sequences
in nuclear proteins that are sufficient and necessary for nu-
clear export, called nuclear export sequences (NESs; for
review see Gerace, 1995). NESs consisting of short amino
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Abbreviations used in this paper
 
: FACS
 
®
 
, fluorescence activated cell
sort(er)ing; GFP, green fluorescent protein; GSK-3, glycogen synthase ki-
nase-3; NES, nuclear export sequence; NFAT, nuclear factor of activated
T cells; NLS, nuclear localization sequence; NPC, nuclear pore complex;
WGA, wheat germ agglutinin.
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acid stretches enriched in leucine residues appear to be the
most prevalent (e.g., Fischer et al., 1995; Wen et al., 1995;
Richards et al., 1996), although a distinct type of NES is
present within the M9 domain of hnRNP A1 (Michael et al.,
1995) and in a sequence of the hnRNP K protein (Michael
et al., 1997). It was recently reported that certain leucine-
rich NESs interact with a member of the importin 
 
b
 
 super-
family called CRM1 (Fornerod et al., 1997
 
b
 
; Fukuda et al.,
1997). CRM1 has been implicated in nuclear export from
in vivo studies involving temperature sensitive CRM1 mu-
tants in yeast (Fukuda et al., 1997; Stade et al., 1997), and
the overexpression of CRM1 in 
 
Xenopus
 
 oocytes (For-
nerod et al., 1997
 
b
 
). Other work has suggested that CRM1
targets the exported substrate to proteins of the NPC
(Neville et al., 1997). Nuclear export of the Rev protein,
which also contains a leucine-rich NES, appears to involve
an additional factor, eIF-5A (Ruhl et al., 1993; Bevec et al.,
1996). CRM1-independent nuclear export has been de-
scribed for importin 
 
a
 
 (Kutay et al., 1997), which also con-
tains a leucine-rich NES (Boche and Fanning, 1997).
Genetic studies in yeast have provided evidence that
Ran has a role in RNA export (e.g., Schlenstedt et al.,
1995). Recent work with vertebrate cells has expanded
upon this, showing that the GTP-bound form of Ran is re-
quired for the nuclear export of a protein containing a leu-
cine-rich NES (Richards et al., 1997) and of various RNAs
(Izaurralde et al., 1997). However, in contrast to nuclear
import, RanGTP hydrolysis does not appear to be neces-
sary for export under these conditions. Although the pre-
cise role of RanGTP in nuclear export in these experi-
ments remains to be elaborated, in vitro studies indicate
that RanGTP stimulates the formation of complexes be-
tween certain export receptors and their cargos (Fornerod
et al., 1997
 
b
 
; Kutay et al., 1997), and suggests a direct role
for Ran in nuclear export.
The availability of a cytosol-dependent in vitro assay for
nuclear export would greatly facilitate the understanding
of nuclear export by allowing the detailed biochemical
characterization of soluble factors involved in this process.
Arts et al. (1997) have described an in vitro assay for ex-
port of RNA from synthetic nuclei, but a cytosolic require-
ment for export in this system is unclear. Yang et al. (1997)
have shown that the glucocorticoid receptor is exported
from nuclei of digitonin-permeabilized cells in an ATP-
and temperature-dependent manner, but the export is ap-
parently independent of exogenous cytosol under their ex-
perimental conditions.
Here we report the development and characterization of
a cytosol-dependent assay for the analysis of nuclear pro-
tein export in permeabilized cells. The model export sub-
strate in our system is the shuttling transcription factor
NFAT (nuclear factor of activated T cells; Northrop et al.,
1994), which plays a crucial role in the activation of T lym-
phocytes by stimulating the transcription of cytokine genes
(for review see Crabtree and Clipstone, 1994). NFAT con-
tains two regulatable NLSs of the basic amino acid type
(Beals et al., 1997
 
a
 
), as well as a regulatable leucine-rich
NES (Klemm et al., 1997). In resting cells, NFAT resides
in the cytoplasm. Its nuclear import is triggered by ele-
vated intracellular calcium (Flanagan et al., 1991; Shiba-
saki et al., 1996), which induces the activation of the phos-
phatase calcineurin, leading to the dephosphorylation of
 
NFAT and subsequent exposure of its NLSs (Beals et al.,
1997
 
a
 
). Upon return of calcium to resting levels, NFAT
rapidly reappears in the cytosol (Shibasaki et al., 1996) by
an export process that requires rephosphorylation of
NFAT by glycogen synthase kinase-3 (GSK-3; Beals et al.,
1997
 
b
 
).
Using our permeabilized cell assay, we have character-
ized the cytosolic requirements for nuclear export of
NFAT. By biochemical fractionation and reconstitution,
we found that Ran and CRM1 are the two major cytosolic
activities involved in NFAT export under our conditions.
Our studies further suggest that the nuclear import of
CRM1 is mediated by a Ran-dependent pathway distinct
from those involving conventional NLSs, and provide the
basis for developing a detailed understanding of the nucle-
ocytoplasmic shuttling of a major nuclear export receptor.
 
Materials and Methods
 
Molecular Cloning of the Green Fluorescent
Protein–NFAT Transfection Vector pAD-4
 
In a first step, the green fluorescent protein (GFP) fragment of the eu-
karyotic expression vector pS65T-C1 (Clontech Laboratories, Inc., Palo
Alto, CA) was replaced with the human codon usage-optimized SGFP–
TYG (synthetic GFP containing the amino acid change 65SYG to
65TYG). SGFP–TYG was amplified from the vector blue-SGFP–TYG-
nosKS (J. Sheen, Harvard Medical School, Boston, MA) by PCR and then
primers were designed to introduce a NheI site and a HindIII site. This
NheI–HindIII fragment encoding SGFP–TYG was introduced into the
eukaryotic expression vector pS65T-C1 (replacing the original GFP se-
quence in the vector), creating pAD-3. In a second step, the coding se-
quence of human NFAT was then PCR amplified out of pSH107c (pro-
vided by G.R. Crabtree, Howard Hughes Medical Institute, Stanford, CA),
inserted into the BamHI and XbaI sites of pAD-3 (resulting in pAD-4),
and then verified by sequencing.
 
Cell Culture and Transfections
 
HeLa cells were grown either in DME on plastic dishes, or in suspension
in Joklik’s modified S-MEM (GIBCO BRL, Gaithersburg, MD). In both
cases media contained 10% FBS, 100 U/ml penicillin, and 100 
 
m
 
g/ml strep-
tomycin. Transfections were performed with lipofectamine (GIBCO
BRL, Gaithersburg, MD) using 25 
 
m
 
g of linearized plasmid per 
 
z
 
2 
 
3 
 
10
 
6
 
adherent cells. Approximately 50 G418-resistant clones (GIBCO BRL)
were pooled and induced with 250 nM of trichostatin A (Wako BioProd-
ucts, Richmond, VA) to express GFP–NFAT. Cells expressing high levels
were enriched by FACS
 
®
 
 (Becton and Dickinson Co., Mountain View,
CA). Positive cells were expanded and stored in aliquots in liquid ni-
trogen.
 
Preparation of Cytosol and Nuclear Extract
 
Approximately 4.5 
 
3 
 
10
 
9
 
 HeLa cells (8 liters of cells growing in suspen-
sion) were collected by centrifugation at 300 
 
g
 
 for 10 min, washed twice
with ice-cold PBS, and then once with washing buffer (10 mM Hepes–
KOH, pH 7.3, 110 mM KOAc, 2mM Mg[OAc]
 
2
 
, 2 mM DTT). After resus-
pension in one volume of lysis buffer (5 mM Hepes–KOH, pH 7.3, 10 mM
KOAc, 2mM Mg[OAc]
 
2
 
, 2 mM DTT, 1 mM PMSF, 1 
 
m
 
g/ml each of leu-
peptin, pepstatin, and aprotinin) and swelling for 10 min on ice, the cells
were lysed in a stainless steel Dounce homogenizer. After centrifugation
at 1,500 
 
g 
 
for 15 min, the supernatant was cleared by centrifugation at
120,000 
 
g
 
 for 1 h and then dialyzed overnight against transport buffer (20
mM Hepes–KOH, pH 7.3, 110 mM KOAc, 2 mM Mg[OAc]
 
2
 
, 1mM
EGTA). The resulting cytosol (
 
z
 
10 mg/ml) was frozen in liquid nitrogen
and stored at 
 
2
 
80
 
8
 
C.
To prepare a nuclear extract, the pellet of the 1,500-
 
g
 
 spin was washed
in 4 ml of lysis buffer and resuspended in 10 ml of 20 mM Hepes–KOH,
pH 7.9, 25% glycerol, 0.5 M NaCl, 1.5 M MgCl
 
2
 
, 0.2 mM EDTA, 1 mM
PMSF, and 1 mM DTT. The nuclei were lysed by 10 strokes in a stainless 
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steel Dounce homogenizer, left on ice for 15 min, and then centrifuged at
35,000 
 
g
 
 for 30 min. The resulting supernatant was dialyzed overnight
against transport buffer and then centrifuged again at 100,000 
 
g
 
 for 30
min. The final supernatant (nuclear extract, 
 
z
 
3.5 mg/ml) was frozen in liq-
uid nitrogen and stored at 
 
2
 
80
 
8
 
C.
 
SDS-PAGE and Western Blotting
 
Proteins were separated by SDS-PAGE and blotted onto nitrocellulose
using standard methods. Blots were blocked with 5% milk powder in PBS
overnight. NFAT was detected with the mouse monoclonal antibody 7A6
(1:5,000 in 5% milk in PBS) and HRP-coupled goat anti–mouse IgG
(Pierce Chemical Co., Rockford, IL; 1:5,000 in 10 mM Tris-HCl, pH 8, 150
mM NaCl, 0.05% Tween 20 [Sigma Chemical Co.]). CRM1 was detected
with different anti-CRM1 antibodies (see below; 1:5,000–1:3,000 in 5%
milk in PBS) and HRP-coupled donkey anti–rabbit IgG (Pierce Chemical
Co.; 1:10,000 in 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.05% Tween 20).
The enhanced chemiluminescence system (Pierce Chemical Co.) was used
for visualization of proteins.
 
Antibodies
 
The mouse monoclonal anti-NFAT antibody (7A6) is described by
Northrop et al. (1994). Anti-importin 
 
b
 
 antibody was obtained from Af-
finity BioReagents, Inc. (clone 3E9; Golden, CO). Before use in the ex-
port assay, the ascites fluid was diluted 1:4 with transport buffer contain-
ing 5 mg/ml BSA and then dialyzed against transport buffer. Two
different polyclonal antibodies against CRM1 were used. The first is de-
scribed by Fornerod et al. (1997
 
a
 
) and was provided by G. Grosveld (St.
Jude Children’s Research Hospital, Memphis, TN). The second was raised
in rabbits by injecting a peptide corresponding to the COOH terminus of
CRM1 (GIFNPHEIPEEMCD), coupled with glutaraldehyde to keyhole
limpet hemocyanin (Calbiochem-Novabiochem Corp., La Jolla, CA).
 
Purification of GST-M9
 
pGEX-M9 provided by G. Dreyfuss (University of Pennsylvania School of
Medicine, Philadelphia, PA) was transformed into DH5
 
a
 
 cells. An over-
night culture was diluted 1:50 in Luria-Bertani medium, grown to an
OD
 
600
 
 
 
of 0.7, and then induced with 1 mM isopropylthio-
 
b
 
-
 
D
 
-galactoside
for 3 h. Cells were harvested by centrifugation at 5,000 
 
g
 
 for 10 min,
washed twice in ice-cold PBS, and then resuspended to 1% of the original
volume in PBS with 5 
 
m
 
g/ml each of aprotinin, leupeptin, and pepstatin.
After cell lysis, Triton X-100 was added to a final concentration of 1%.
The lysate was centrifuged at 10,000 
 
g
 
 for 10 min and the supernatant was
incubated with glutathione–Sepharose 4B beads (Pharmacia Biotech. Inc.,
Piscataway, NJ) for 1 h at 4
 
8
 
C. The beads were collected by centrifugation
at 800 
 
g
 
 for 5 min and then washed in batch three times in PBS and once in
50 mM Tris-HCl, pH 8.8, 150 mM NaCl before being transferred to a col-
umn. GST-M9 was eluted with 50 mM Tris base, 150 mM NaCl, and 15
mM glutathione (reduced). Peak fractions were dialyzed against 100 mM
Hepes–KOH, pH 9.6.
 
Recombinant Import Factors
 
Wild-type Ran was prepared as described (Melchior et al., 1995).
RanQ69L and RanT24N were obtained from J. Becker (MPI für moleku-
lare Physiologie, Dortmund, Germany) (Klebe et al., 1995). Importin 
 
a
 
and importin 
 
b
 
 were prepared as in Hu et al. (1996). NTF2 was prepared
as in Paschal and Gerace (1995).
 
Preparation of Fluorescent Import Substrates
 
To prepare Cy5-NLS-BSA, 2.5 mg of BSA in 1 ml 0.1 M Na
 
2
 
CO
 
3 
 
was cou-
pled to Cy5™ (1 vial, Amersham Pharmacia Biotech. Inc., Piscataway, NJ)
for 40 min at room temperature. The conjugate was separated from the
free dye by chromatography on a PD-10 column (Pharmacia Biotech.
Inc.). The NLS peptide derived from the sequence of the SV-40 large T
antigen was reduced as described (Adam et al., 1990) and coupled to Cy5-
BSA that had previously been activated with a 20-fold molar excess of
sulfo-SMCC (Pierce Chemical Co.; Adam et al., 1990) by incubation at
4
 
8
 
C overnight. The Cy5–NLS-BSA conjugate was then separated from
free peptide by chromatography on a PD-10 column equilibrated with
transport buffer. Peak fractions were pooled and then aliquots were fro-
zen in liquid nitrogen.
To prepare Cy5–GST-M9, 5 mg of GST-M9 was coupled with Cy5™ (1
vial, Amersham Pharmacia Biotech. Inc.) for 30 min at room temperature
and then separated from free dye by chromatography on a PD-10 column
(Pharmacia Biotech. Inc.). Peak fractions of Cy5–GST-M9 were pooled
and diluted with transport buffer to a final concentration of 1 mg/ml. Ali-
quots were frozen in liquid nitrogen.
 
Nuclear Export Assay
 
To assay nuclear export of NFAT, its expression was induced by treating
stably transfected HeLa cells growing on tissue culture dishes with 250 nM
of trichostatin A (Wako BioProducts) overnight. To induce nuclear im-
port, ionomycin (Calbiochem-Novabiochem Corp.) and LiOAc were
added to final concentrations of 1 
 
m
 
M and 30 mM, respectively, and then
the cells were incubated for 30 min at 37
 
8
 
C. They were trypsinized in the
continued presence of ionomycin and LiOAc and then washed once with
10% FBS in transport buffer and once with transport buffer containing
80 mM KOAc, 30 mM LiOAc, 2 mM DTT, 1 mM PMSF, and 1 
 
m
 
g/ml each
of leupeptin, pepstatin, and aprotinin. The cells were collected by centrif-
ugation at 300 
 
g 
 
for 5 min at 4
 
8
 
C and then resuspended in transport buffer
(with 30 mM LiOAc) at 
 
z
 
10
 
7
 
/ml. After permeabilization with 60 
 
m
 
g/ml
digitonin (Calbiochem-Novabiochem Corp.) for 5 min on ice, the cells
were washed and centrifuged as described above and then resuspended to
a concentration of 10
 
7
 
/ml in transport buffer containing KOAc and
LiOAc. A preincubation in the presence of an ATP-regenerating system
was performed for 15 min at 0
 
8
 
C or 30
 
8
 
C. Cells were then washed in trans-
port buffer lacking LiOAc but containing 110 mM KOAc and then resus-
pended at 
 
z
 
3 x 10
 
7
 
/ml. The complete transport mixture (40 
 
m
 
l in transport
buffer) contained 
 
z
 
300,000 cells, an ATP-regenerating system (1 mM
ATP, 5 mM creatine phosphate, 20 U/ml creatine phosphokinase), 2.5 mg/
ml BSA, import ligand (Cy5–NLS-BSA at 
 
z
 
2.5 
 
m
 
g/ml or Cy5–GST-M9 at
 
z
 
25 
 
m
 
g/ml), 1 
 
m
 
M of annealed oligonucleotide (5
 
9
 
 AGA GGA AAA TTT
GTT TCA TA and 5
 
9
 
 TAT GAA ACA AAT TTT CCT CT, both pre-
pared and HPLC purified by GIBCO BRL), and cytosol or nuclear ex-
tract at various concentrations, as indicated. For reactions in the absence
of ATP, the ATP-regenerating system was replaced by 50 U/ml hexoki-
nase (Sigma Chemical Co.) and 12.5 mM glucose. Reactions were incu-
bated at 30
 
8
 
C for 30 min and stopped by the addition of ice-cold transport
buffer. After centrifugation at 300 
 
g 
 
for 5 min at 4
 
8
 
C, the cells were resus-
pended in a small volume of transport buffer. The average nuclear fluo-
rescence emitted from GFP–NFAT, Cy5–NLS-BSA, or Cy5–GST-M9 in
10,000 cells was measured with a FACScan
 
®
 
 flow cytometer (Becton and
Dickinson Co.). Reactions were standardized by arbitrarily assigning a
value of 100 to the nuclear fluorescence of GFP–NFAT in a 0
 
8
 
C control
reaction and, unless otherwise indicated, to the maximal nuclear fluores-
cence of the imported ligands after incubation at 30
 
8
 
C. For export reac-
tions in which permeabilized cells were not preincubated, treatment of
cells was as described above, except that transport buffer always con-
tained 110 mM KOAc and no LiOAc. For analysis of export by SDS-
PAGE, nuclei were collected by centrifugation upon completion of the
export reaction, washed once in transport buffer, and then resuspended in
SDS-sample buffer. The supernatant of the first centrifugation was re-
tained and mixed with an equal volume of 2
 
3
 
 SDS-sample buffer and nu-
clei and supernatant fractions were analyzed by SDS-PAGE and immuno-
blotting. To perform the export assay with adherent cells growing on
coverslips, cells were treated with trichostatin A and ionomycin as above,
permeabilized with digitonin, and then subjected to export reactions in
the same manner as previously described for nuclear import reactions
(Adam et al., 1990). Cells were then fixed with 3.7% formaldehyde in PBS
and analyzed by fluorescence microscopy using an Axiophot (Carl Zeiss,
Inc., Thornwood, NY).
 
Purification of a Major Cytosolic Activity for
Nuclear Export
 
6 ml of cytosol (containing 60 mg of protein) were dialyzed into triethanol-
amine buffer (20 mM triethanolamine, pH 7.4, 2 mM MgCl
 
2
 
) and satu-
rated ammonium sulfate was added to a final concentration of 900 mM.
The precipitate (6% of total protein) was collected by centrifugation
(14,000 
 
g
 
 for 5 min) and then resuspended in triethanolamine buffer. The
remaining ammonium sulfate was removed by chromatography of the dis-
solved precipitate on a PD-10 column (Pharmacia Biotech. Inc.) equili-
brated in triethanolamine buffer. The sample then was loaded on a FPLC
Mono Q column (HR 5/5; Pharmacia Biotech. Inc.) and eluted with a 20-ml
linear gradient of 100 to 350 ml NaCl in triethanolamine buffer using a 
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flow rate of 0.4 ml/min and collecting 1-ml fractions. Maximal nuclear ex-
port activity was typically recovered at 
 
z
 
230 mM NaCl. 900 
 
m
 
l of the peak
fraction (as determined by the nuclear export assay and by immunoblot-
ting) were concentrated to 300 
 
m
 
l by vacuum dialysis applied to a gel fil-
tration column (Superdex 200 HR 10/30; Pharmacia Biotech. Inc.) equili-
brated in transport buffer. The sample was chromatographed at 0.5 ml/
min, collecting 0.5-ml fractions. The nuclear export activity eluted with a
molecular mass of 
 
z
 
120 kD.
 
Results
 
We have developed a method for rapid, quantitative anal-
ysis of nuclear export of the shuttling transcription factor
NFAT in permeabilized HeLa cells. For this, we prepared
cells that were stably transfected with a cDNA coding for
NFAT fused to the GFP. The expression of GFP–NFAT
was induced to high levels by overnight treatment of the
cells with the histone deacetylase inhibitor trichostatin A
(Fig. 1) or with sodium butyrate (data not shown; Gorman
et al., 1983; Arts et al., 1995). The actual level of expres-
sion of the GFP–NFAT in the induced cell population var-
ied from cell to cell, although typically about two-thirds of
the cells expressed high levels of GFP–NFAT (Fig. 2 
 
a
 
, 
 
2 
 
ion
 
).
The range of expression levels in the cell population was
most clearly seen in cells analyzed by flow cytometry (see
Fig. 3 
 
b
 
, 
 
0
 
8
 
C
 
).
The GFP–NFAT in the transfected cells exhibited the
same nuclear transport behavior and responses to inhibi-
tors as originally described for wild-type NFAT in vivo.
The calcium ionophore ionomycin induced rapid nuclear
import of GFP–NFAT (Flanagan et al., 1991; Shibasaki et al.,
1996), which was predominantly cytoplasmic in untreated
cells (Fig. 2 
 
a
 
, compare 
 
2 
 
ion
 
 with 
 
1
 
 
 
ion
 
). GFP–NFAT
from ionomycin-treated cells had a higher electrophoretic
mobility on an SDS gel than the protein from untreated
cells (Fig. 1, in vivo, compare 2 ion and 1 ion lanes), re-
flecting a partial dephosphorylation of the protein (Ruff
and Leach, 1995). The ionomycin-induced import of GFP–
NFAT into the nucleus was inhibited by simultaneously
adding cyclosporin A, a specific inhibitor of calcineurin
(Flanagan et al., 1991; Liu et al., 1991; data not shown).
When the ionomycin-treated cells were washed and incu-
bated at 378C in the presence of cyclosporin A, GFP–
NFAT was rapidly exported from the nucleus (Shibasaki
et al., 1996; data not shown). Finally, export of GFP–
NFAT was inhibited by the addition of 30 mM of lithium
acetate to the medium, which inhibits its rephosphoryla-
tion by inactivating GSK-3 (Klein and Melton, 1996; data
not shown). Considered together, these in vivo experi-
ments indicate that HeLa cells expressing GFP–NFAT are
appropriate for use in an in vitro nuclear export assay.
Nuclear Export of GFP–NFAT In Vitro
After the expression of GFP–NFAT was induced in stably
transfected HeLa cells, the nuclear import of the reporter
was triggered by treatment with ionomycin. Next, the cells
were removed from the dish by trypsinization, permeabi-
lized with digitonin, and then washed to remove the en-
dogenous cytosol. In our standard export assay, the per-
Figure 1. Detection of GFP–NFAT
in total cell lysates (in vivo) or after
export reactions (in vitro). In vivo:
transfected HeLa cells were treated
with (1) or without (2) 250 nM tri-
chostatin A (TSA) overnight and
with (1) or without (2) 1 mM iono-
mycin (ion) for 30 min. GFP–NFAT from total cell lysates
(z20,000 cells) was detected by immunoblotting. In vitro: cells
were treated with trichostatin A and ionomycin as above. After
standard nuclear export reactions at 08C or 308C, GFP–NFAT in
the permeabilized cell/nuclear fraction (N) or in the supernatant
(S) was detected by immunoblotting.
Figure 2. Nuclear trafficking of GFP–NFAT in vivo and in vitro.
(a) Transfected HeLa cells were treated overnight with trichosta-
tin A and incubated for 30 min plus (1 ion) or minus (2 ion) ion-
omycin. (b) Standard nuclear export reactions were performed
on coverslips. Permeabilized cells were incubated at 08C or 308C
in the presence of 2 mg/ml of cytosol and 25 mg/ml of Ran. For
the reaction without ATP (2 ATP), the ATP-regenerating system
was replaced by an ATP-depleting system. WGA was added to
200 mg/ml as indicated. Note that some cells express very little, if
any, GFP–NFAT (see panels for 2 ion, 1 ion, and 08C incubation).Kehlenbach et al. Shuttling Factors in Nuclear Export 867
meabilized cells were first preincubated for 15 min at 308C
in the absence of cytosol and in the presence of ATP. To
retain most of the GFP–NFAT in the nucleus during the
preincubation step, we included lithium in the preincuba-
tion buffer to inhibit GSK-3 (refer to Introduction and
Materials and Methods). Typically, between 80 and 90%
of the GFP–NFAT remained in the nucleus after the pre-
incubation (data not shown). Subsequently, the cells were
incubated under various export conditions in the absence
of lithium and were analyzed by flow cytometry. As shown
below, the 308C preincubation step depletes rate-limiting
export factors from the permeabilized cells, thereby allow-
ing the detection of these activities in the subsequent ex-
port assay.
A double-stranded oligonucleotide corresponding to an
NFAT DNA-binding site (Northrop et al., 1994) was in-
cluded in all export reactions. This oligonucleotide stimu-
lated in vitro ATP-dependent nuclear export of GFP–
NFAT approximately twofold at a concentration of 1 mM
(data not shown), apparently by promoting release of the
protein from chromatin (see below). Export reactions in
the absence of the oligonucleotide gave qualitatively simi-
lar results, although the absolute levels of export were
lower. Interestingly, the addition of lithium to export reac-
tions containing oligonucleotide did not significantly de-
crease the level of GFP–NFAT export (data not shown).
This indicates that the inclusion of the oligonucleotide ab-
rogates the requirement for phosphorylation by GSK-3 for
efficient export. Thus, the lithium-sensitive phosphoryla-
tion of NFAT appears to stimulate export by releasing
NFAT from chromatin, not by activating an NES on
NFAT per se. Decreased DNA binding activity of NFAT
upon phosphorylation has been described previously (Park
et al., 1995).
Fluorescence micrographs of permeabilized cells that
had been incubated in the standard export assay are
shown in Fig. 2 b. When cells were incubated at 08C, the
amount of GFP–NFAT retained in the nucleus (Fig. 2 b;
08C) was essentially identical to the amount retained in the
nuclei of cells examined immediately after permeabiliza-
tion (data not shown). In contrast, incubation at 308C in
the presence of cytosol and an ATP-regenerating system
led to the loss of most nuclear fluorescence (Fig. 2 b;
308C). The export of GFP–NFAT, as seen by the loss of
fluorescence, was largely prevented if the reaction in-
cluded an ATP-depleting system (Fig. 2 b; 2ATP) or
wheat germ agglutinin (WGA; Fig. 2 b; 1WGA), which
binds to a group of O-glycosylated proteins of the NPC
(Hanover et al., 1987) and inhibits mediated nuclear im-
port and export in vivo (Yoneda et al., 1987; Dargemont
and Kühn, 1992). As shown below, nuclear export of
GFP–NFAT was largely dependent on the addition of cy-
tosol (see Figs. 4 b and 5 b).
Flow cytometry provided a rapid and quantitative
method to analyze nuclear export in a large number of
cells. Fig. 3 shows the result of a standard nuclear export
assay carried out in the presence of cytosol that was ana-
lyzed by this method. The original flow cytometry data
used to generate the graph in Fig. 3 a is shown in Fig. 3 b.
It should be noted that in assays measuring nuclear export,
low values of nuclear fluorescence indicate high levels of
transport, whereas in assays measuring nuclear import
(see below), high fluorescence values represent high levels
of transport. Incubation at 308C resulted in the retention
of only 18.2 units of nuclear fluorescence as compared
with 100 units retained in the 08C control (Fig. 3 a). Export
was strongly inhibited by depleting ATP or by including
the lectin WGA, both of which gave export values similar
to the 08C control (Fig. 3 a).
Several controls indicated that the loss of fluorescence
during the export incubations was due to physiologically
relevant export of GFP–NFAT from intact nuclei. When
we included rhodamine-labeled dextrans of different mo-
lecular weights in the export reactions (Melchior et al.,
1993), we found that a small dextran (4.5 kD), but not a
Figure 3. Characterization of temperature and ATP require-
ments of nuclear export by flow cytometry. Standard nuclear ex-
port reactions were performed in the presence of cytosol. For re-
actions in the absence of ATP (2 ATP), the ATP-regenerating
system was replaced by an ATP-depleting system. WGA was
used at 200 mg/ml. All reactions contained recombinant Ran at 25
mg/ml. (b) Original FACS® profiles used to obtain the data in a
and distribution of fluorescence values in the population of per-
meabilized cells. The absolute level of export of GFP–NFAT var-
ied from assay to assay, although in a single experiment duplicate
reactions gave very similar results. Very similar profiles were ob-
tained with cells before permeabilization and in permeabilized
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large one (155 kD) was able to enter the nucleus (data not
shown). This demonstrated that the permeability barrier
of the nuclear envelope remained normal. Additional vali-
dation for the integrity of the nuclear envelope was ob-
tained by incubating permeabilized cells with Cy5-labeled
NLS-BSA and cytosol in the standard export assay. In this
case, efficient nuclear accumulation of the NLS-BSA oc-
curred at the same time as export of the GFP–NFAT (see
Fig. 4), and both the import and export were inhibited by
WGA (data not shown). A further control involved centri-
fuging the assay mixture after the export reaction and ex-
amining the resulting supernatants and pellets by Western
blotting to detect GFP–NFAT (refer to Fig. 1). The total
amount of GFP–NFAT in a reaction incubated at 308C
was similar to that in a reaction incubated at 08C. How-
ever, in the 08C incubation, most of the GFP–NFAT was
found in the permeabilized cell pellet, whereas in the 308C
incubation, most of the GFP–NFAT was found in the su-
pernatant. Thus, the loss of GFP fluorescence at 308C does
not result from degradation of GFP–NFAT, but instead
reflects its release from the permeabilized cells into the su-
pernatant. It should be noted that after incubation at 308C,
the electophoretic mobility of GFP–NFAT decreases and
resembles that of the protein before nuclear import in vivo
(refer to Fig. 1, compare in vivo with in vitro panels). This
apparently reflects rephosphorylation of the NFAT, which
activates the export of NFAT and inactivates its NLS in vivo
(Beals et al., 1997). Since calcineurin-mediated dephosphor-
ylation of GFP–NFAT cannot occur in vitro due to the pres-
ence of EGTA in our assay buffer, the exported GFP–NFAT
is trapped outside the nucleus and cannot be reimported.
Further Characterization of the Standard Nuclear 
Export Assay
To further characterize nuclear transport in the standard
export assay, we simultaneously measured export of GFP–
NFAT and import of Cy5–NLS-BSA in the same cells
(Fig. 4). Fig. 4 a shows a concurrent time course of nuclear
import and export over a range of 30 min. Nuclear import
of Cy5–NLS-BSA was linear for at least 30 min, yielding a
final value that was approximately sixfold greater than the
08C background (100 versus 16.4 units). Examination of
nuclear export of GFP–NFAT in the same cells showed
that the fluorescent signal of GFP–NFAT was reduced
from 100 units at the beginning of the reaction to a final
typical value of 24.5 units after a 30-min incubation. Nu-
clear export was roughly linear for 15–20 min and then
started to level off, which was probably due to a limitation
of the export substrate after this time. In cells expressing
much lower levels of GFP–NFAT, export was linear for
only z10 min (data not shown).
Fig. 4 b shows a comparison of the cytosol requirement
of nuclear import and nuclear export. The reactions were
carried out in the presence of excess recombinant Ran so
that it would not be rate limiting. We found that 1.25 mg/ml
cytosol stimulated nuclear export of GFP–NFAT to al-
most the maximal level (from 72.9 to 19 units) and also
gave maximal stimulation of import of Cy5–NLS-BSA
into the nucleus (from 21.7 to 100 units). Thus, the cytosol
requirement for nuclear import and export is quantita-
tively very similar under these conditions.
Under steady-state conditions, nuclear export factors
are expected to be somewhat concentrated in the nucleus.
Therefore, we tested the ability of a HeLa cell nuclear ex-
tract to stimulate nuclear export. Fig. 4 c shows that the
nuclear extract stimulated export of GFP–NFAT to
roughly the same extent as did cytosol when used at the
same protein concentration (from 100 units at 08C to 28.6
units for nuclear export, compared with 23.6 units for cyto-
sol). In contrast, the nuclear extract had only a minor stim-
ulatory effect on protein import into the nucleus as com-
pared with cytosol (from 14 units at 08C, to 22.6 and 100
Figure 4. General characteristics of nuclear export under stan-
dard assay conditions. (a) Time course of standard nuclear ex-
port/import reactions (2 mg/ml of cytosol and 25 mg/ml of Ran in
all reactions). (b) Cytosol dependence of standard nuclear ex-
port/import reactions (50 mg/ml of Ran in all reactions). (a and b)
Closed circles, export; open squares, import. (c) Standard nuclear
export/import reactions were performed at 08C (black bars) or at
308C with either 2 mg/ml of cytosol (hatched bars) or 2 mg/ml of
nuclear extract (grey bars) and 25 mg/ml of Ran in all reactions.
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units at 308C for the nuclear extract and cytosol, respec-
tively). A nuclear extract prepared with a low-salt extraction
buffer (50 mM NaCl) was able to stimulate nuclear export
at least as well as the nuclear extract prepared with a high-
salt buffer (500 mM NaCl, refer to Materials and Methods),
suggesting that the extracted factors are not tightly bound
to NPCs and are probably intranuclear (data not shown).
These results suggest that factors distinct from those re-
quired for the nuclear import of NLS-containing substrates
are involved in the export of GFP–NFAT from the nu-
cleus. The recombinant factors other than Ran that support
the nuclear import of cargoes with classical NLS in perme-
abilized cells (NTF2, importin a, and importin b) strongly
stimulated import of Cy5–NLS-BSA into the nucleus with-
out affecting export of GFP–NFAT (data not shown).
Thus, whereas some or all of these import factors are rate-
limiting for the nuclear import of a protein containing a
classical NLS in our system, none of these components are
rate-limiting in the assay measuring export of GFP–NFAT.
Ran and Other Nucleocytoplasmic Shuttling Factors 
Are Involved in Nuclear Export of NFAT
Ran has a well-established role in nuclear import and re-
cent studies have suggested a direct role for Ran in nuclear
export as well (refer to Introduction). To investigate a pos-
sible involvement of Ran and other nucleocytoplasmic
shuttling factors in nuclear export in our assay, we ana-
lyzed the stimulation of nuclear export of GFP–NFAT by
Ran alone or by cytosol, after preincubation of the perme-
abilized cells either at 08C or at 308C in the presence of
ATP and absence of cytosol (Fig. 5, a and b). The preincu-
bation at 308C, as used in our standard assay, might be ex-
pected to deplete rate-limiting export factors whose exit
from the nucleus is ATP- and temperature-dependent,
whereas the preincubation at 08C would deplete only fac-
tors that are small enough to exit the nucleus by passive
diffusion. Previous work has shown that Ran is almost
completely depleted from the nucleus of permeabilized
cells during digitonin treatment and washing at 08C (Mel-
chior et al., 1995).
In permeabilized cells that had been preincubated at
08C, Ran alone strongly stimulated export to a degree that
was similar to the export stimulation obtained with com-
plete cytosol (Fig. 5, compare a with b): the fluorescence
decreased from 81.2 units after incubation with buffer to
34.3 units with Ran (100 mg/ml) or to 37.6 units with cyto-
sol (5 mg/ml). By contrast, in cells that had been preincu-
bated at 308C, Ran by itself only weakly stimulated nu-
clear export (reducing the fluorescence from 87.2 to 67.4
units), whereas cytosol still stimulated export to the same
extent as in cells preincubated at 08C (reducing fluores-
cence from 87.2 to 28.9 U; Fig. 5, a and b). These results in-
dicate that Ran is a rate-limiting export factor that is de-
pleted from cells that have been preincubated at 08C, whereas
additional rate-limiting factors are depleted from the nu-
cleus by preincubating the permeabilized cells at 308C.
We next investigated the effect of the RanQ69L and
RanT24N mutants on nuclear export in cells that had been
preincubated at 08C to deplete Ran only but not other
rate-limiting export factors. RanQ69L cannot hydrolyze
GTP and thus, is predominantly in the GTP-bound form
(Klebe et al., 1995). RanT24N is either in the nucleotide-
free state or bound to GDP (Klebe et al., 1995). These two
mutants are well-characterized inhibitors of nuclear pro-
tein import, both in vivo (Dickmanns et al., 1996) and in
permeabilized cells (Palacios et al., 1996). Interestingly, in-
creasing concentrations of RanQ69L progressively stimu-
lated nuclear export of GFP–NFAT in the absence of cy-
tosol (Fig. 5 c; from 83.9 units without addition to 67.2
units with 40 mg/ml of RanQ69L), albeit to a lower extent
than the stimulation obtained with cytosol (from 83.9 to
Figure 5. Preincubation leads to a loss of rate-limiting factors for
nuclear export. Standard nuclear export reactions were per-
formed with increasing amounts of Ran (a) or cytosol (b) after
preincubation of the permeabilized cells at either 08C (closed cir-
cles) or 308C (open squares). (c) Nuclear export reactions after
preincubation at 08C were performed with increasing amounts of
RanQ69L in the absence (2 cytosol, closed circles) or presence
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41.9 units) or with wild-type Ran (data not shown; also com-
pare Fig. 5, a with b). However, in the presence of cytosol,
RanQ69L inhibited export from 41.9 to 68.2 units, a value
that is very similar to that observed with RanQ69L alone
(67.2 units). In cells that had been preincubated at 308C,
RanQ69L had no effect on nuclear export in the absence
of cytosol and had an inhibitory effect in the presence of
cytosol (data not shown). RanT24N had no effect on nu-
clear export in the absence of cytosol and inhibited export
in the presence of cytosol in cells that had been preincu-
bated at 08C (data not shown).
These data indicate that Ran has a dual effect on nuclear
export of GFP–NFAT in vitro. One effect reflects the ability
of GTP-bound Ran to stimulate nuclear export in the ab-
sence of nuclear protein import and of RanGTP hydrolysis,
resulting in a moderate increase in export when RanQ69L
is added to the export assay. This effect is consistent with
recent results indicating that RanGTP, but not GTP hy-
drolysis, is required for nuclear export of several substrates
(Izaurralde et al., 1997; Richards et al., 1997). A second ef-
fect involves the additional stimulation of export by wild-
type Ran, which allows GTP hydrolysis. We suggest that this
stimulatory effect reflects the RanGTP hydrolysis-depen-
dent import of rate-limiting export factors into the nucleus.
This Ran-dependent import appears to be inhibited by ei-
ther RanQ69L or RanT24N, resulting in an inhibition of
export by these mutants in the presence of cytosol.
Well-characterized Pathways for Mediated Nuclear 
Protein Import Are Not Required for Nuclear Export of 
NFAT In Vitro
Since our data indicate that our standard nuclear export
assay requires the nuclear import of export factors by a
Ran-dependent–mediated pathway, we analyzed whether
the well-characterized pathways for import of proteins
containing either a basic amino acid-rich NLS or the M9-
type NLS are involved. To address this we performed ki-
netic competition experiments with either classical NLS-
BSA or GST-M9 transport substrates, and also carried out
antibody inhibition experiments to inactivate importin b,
which is involved in import of proteins containing basic
amino acid-type NLSs (refer to Introduction).
Fig. 6 a shows that a high concentration of NLS-BSA in-
hibited the nuclear import of Cy5–NLS-BSA (from 100
fluorescent to 18 units, with a 08C background of 14 units).
In contrast, nuclear export was not significantly affected
by NLS-BSA (resulting in 27 units in the presence of
NLS-BSA, as compared with 23.6 units without NLS-BSA).
We next examined the effects of a monoclonal antibody
against importin b that inhibits nuclear import of NLS-
containing substrates (Chi et al., 1995). In the presence of
cytosol, this antibody reduced the level of import of Cy5–
NLS-BSA into the nucleus approximately fourfold with-
out affecting export of GFP–NFAT (data not shown). In
the presence of a nuclear extract, which supports import
to a much lower extent than cytosol (see above), the anti-
Figure 6. Import of export factors by a nonconventional path-
way. (a and c) Competition of import and export: reactions were
performed in the absence (08C, black bars and 308C, 2 competi-
tor, hatched bars) or presence (308C, white bars) of 0.5 mg/ml un-
labeled NLS–BSA (a, 1 NLS-BSA) or 0.5 mg/ml GST-M9 (c, 1
GST-M9). Cy5–NLS-BSA (a) or Cy5–GST-M9 (c) was used as a
fluorescent import substrate. (b) Anti-importin b antibody abol-
ishes import but not export. Reactions were performed in the
presence of 2 mg/ml of cytosol (08C, black bars and 1 cytosol,
308C, hatched bars) or 1.5 mg/ml nuclear extract (1 nuclear ex-
tract, 308C, grey bars and 1 nuclear extract 1 anti-importin b,
308C, white bars). 4 ml of the monoclonal antibody against impor-
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importin b antibody completely blocked import (Fig. 6 b):
fluorescence was reduced from 41.6 units with buffer to
16.1 units with antibody; a 08C control resulted in 16.3 units.
Again, the antibody had only a minor effect on the nuclear
export of GFP–NFAT (30.2 units with antibody compared
with 25.4 units with buffer).
Similar to the results with NLS-BSA, unlabeled GST-
M9 competed for the import of Cy5–GST-M9 (Fig. 6 c).
The fluorescence was reduced from 100 to 45.6 units with a
08C background of 23.2 units (in this case the applied con-
centration of GST-M9 was not high enough to achieve
complete inhibition). In contrast, the export of GFP–NFAT
remained essentially unchanged under these conditions
(resulting in a fluorescence of 17.8 units with competitor, com-
pared with 16.9 units without competitor). These results
indicate that the nuclear protein import pathways speci-
fied by the two well-characterized NLSs are not involved
in nuclear export of GFP–NFAT. Thus, the nuclear export
factors provided by exogenously added cytosol or nuclear
extract appear to reenter the nucleus by a nonconven-
tional-mediated import pathway that is dependent on Ran.
CRM1 Is a Major Cytosolic Export Factor In Vitro
Since Ran alone was unable to support export after prein-
cubation at 308C to the same extent as cytosol (refer to
Fig. 5, a and b), we carried out biochemical fractionation
of cytosol to isolate a major activity other than Ran that
promotes nuclear export in our assay. As an initial purifi-
cation step, we enriched approximately half of the export
activity by a selective ammonium sulfate precipitation step
(data not shown; refer to Materials and Methods). The
sample from ammonium sulfate precipitation then was
loaded onto a Mono Q ion exchange column and then in-
dividual fractions were tested for their ability to stimulate
nuclear export in our standard assay in the presence of an
excess of exogenous Ran (Fig. 7 a). A single strong peak of
export-stimulating activity was obtained from this column.
Fraction 22, which had the highest activity, reduced the
nuclear fluorescence from a background of 69.2 to 39.2
units. A saturating amount of total cytosol supported nu-
clear export to the same extent as fraction 22 (data not
shown). Since CRM1 has been implicated as an export re-
ceptor for certain leucine-rich NESs (refer to Introduction),
we also analyzed the column fractions for the presence of
CRM1 using immunoblotting (Fig. 7 a, inset). Interest-
ingly, the peak of export activity in this column precisely
coincided with the elution profile of CRM1. The peak frac-
tion from the Mono Q column was subsequently chromato-
graphed onto a gel filtration column, fractions were tested
for their ability to stimulate nuclear export under standard
conditions in the presence of excess Ran, and were also im-
munoblotted to detect CRM1 (Fig. 7 b). A single peak of ex-
port activity was detected in this column profile, and again,
the peak coincided with the elution of CRM1. The export
activity peak and CRM1 eluted at the position of a mono-
Figure 7. CRM1 is a nuclear export factor in
vitro. (a) Activity profile of fractions from the
Mono Q column. Standard nuclear export reac-
tions were performed using 25 ml of Mono Q
fractions that had been dialyzed against trans-
port buffer plus 50 mg/ml of Ran. Inset, immuno-
blot of the indicated fractions with anti-CRM1
antibodies. CRM1 was not detected in any other
fractions. (b) Activity profile of fractions from
the Superdex 200 column. Standard nuclear ex-
port reactions were performed using 30 ml of Su-
perdex 200 fractions and 50 mg/ml of Ran. Inset,
immunoblot of the indicated fractions with anti-
CRM1 antibodies. CRM1 was undetectable in
the other fractions. (c) Silver-stained SDS gel
(7.5%) of selected fractions from the Superdex
200 column in the region of the activity peak.
Whereas certain background bands are seen in
all fractions, the band migrating at the position
of CRM1 was detected mainly in fractions 12–14.
Note that the z100-kD band in fractions 9 and
10 migrates distinctly faster than CRM1. A 10–
20% gradient gel did not reveal any protein
bands in the range between 20 and 50 kD in frac-
tions 12–14 (data not shown). (d) Standard nu-
clear export reactions were performed by incubating permeabilized cells with or
without partially purified CRM1 obtained from a Mono Q fraction, with or with-
out 50 mg/ml of Ran as indicated. (e) HeLa cells were permeabilized with digito-
nin and equivalent amounts of fractions containing permeabilized cells/nuclei (N,
lane 1) and released cytosol (C, lane 2) before preincubation, or permeabilized
cell/nuclei (N) and supernatant (S) after preincubation either at 08C (lanes 3 and 4)
or 308C (lanes 5 and 6) were analyzed by immunoblotting. In contrast to CRM1,
the vast majority of proteins was recovered in the permeabilized cell/nuclei frac-
tion after preincubation at either temperature (lanes 3–6) as seen by Ponceau
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disperse protein at z120 kD (Fig. 7 b, inset), a size very sim-
ilar to the calculated molecular mass (123 kD) of CRM1
(Fornerod et al., 1997a). Fraction 13, which had the high-
est activity, stimulated nuclear export of NFAT from 63.8
to 47.3 units. In comparison, cytosol reduced the nuclear
fluorescence to 23.4 units in this assay. As shown by silver
staining, CRM1 appeared to be the only protein in the
most active fractions (Fig. 7 c). In other experiments, we were
able to recover larger amounts of export activity (and also of
CRM1 antigen) by including 100 mg/ml BSA in the gel fil-
tration column buffer. With Ran and the CRM1 obtained in
this preparation, we obtained a level of nuclear export that
was comparable to that seen with cytosol (data not shown).
Fig. 7 d depicts the export activity of a partially purified
CRM1 fraction in the absence and presence of exogenous
Ran. Whereas little export was obtained with CRM1 alone
or with Ran alone, strong stimulation was obtained with a
combination of CRM1 and Ran (from 79.3 units of nuclear
fluorescence in the absence of both proteins to 36.6 units).
This demonstrates that Ran is required together with
CRM1 to reconstitute in vitro export of NFAT in our stan-
dard export assay.
To further evaluate the role of CRM1 as an export fac-
tor in our assay, we analyzed the distribution of endoge-
nous CRM1 during cell permeabilization and preincuba-
tion to determine whether its fractionation behavior
paralleled the presence of nuclear export activity (Fig. 7 e).
After digitonin permeabilization, the majority of CRM1
was recovered in the cytosolic fraction (Fig. 7 e, lane 2), al-
though a significant amount of the protein remained in the
permeabilized cells (Fig. 7 e, lane 1). Some additional
CRM1 protein was removed from permeabilized cells by a
08C incubation (Fig. 7 e, lanes 3 and 4). However, preincu-
bation of cells at 308C in the absence of cytosol led to the
loss of the great majority of the remaining CRM1 from the
permeabilized cells (Fig. 7 e, lane 6), leaving only a small
amount behind (Fig. 7 e, lane 5). Thus, most CRM1 is re-
leased from the permeabilized cells during the 308C prein-
cubation step when the loss of export activity occurs,
whereas substantial CRM1 remains after a 08C preincuba-
tion step when the permeabilized cells still support strong
export. In further experiments, we found that leptomycin
B, a drug that inhibits the formation of a complex between
CRM1 and NES substrates and thus blocks nuclear export
in vivo (Fornerod et al., 1997b, Fukuda et al., 1997, Ossa-
reh-Nazari et al., 1997), inhibited nuclear export in our in
vitro assay at submicromolar concentrations (data not
shown). Moreover, when we immunodepleted CRM1 from
cytosol, we found that the antibody-depleted cytosol had
substantially reduced nuclear export activity when com-
pared with cytosol that had been treated with a nonspecific
IgG (data not shown). Considering these observations to-
gether with the results of our biochemical fractionation
and reconstitution studies, we conclude that CRM1 and
Ran are nucleocytoplasmic shuttling factors that are re-
quired for the nuclear export of NFAT.
Discussion
An In Vitro Assay for Nuclear Export of NFAT
We have used the shuttling transcription factor NFAT as a
transport substrate to develop a rapid, quantitative in vitro
assay to study nuclear protein export. In our standard ex-
port assay, the permeabilized cells are subjected to a pre-
incubation step at 308C in the absence of cytosol. This step
depletes shuttling export factors from the nucleus under
conditions in which the nuclear export of GFP–NFAT is
reversibly arrested. During a subsequent incubation, effi-
cient export of GFP–NFAT can be achieved if nuclear or
cytosolic extracts are added to the permeabilized cells. Nu-
merous criteria demonstrate that the assay reflects physio-
logically relevant in vitro export of GFP–NFAT. Nuclear
export occurs in a time-, temperature-, and ATP-depen-
dent manner, and can be blocked by WGA, a reagent that
is known to inhibit signal-mediated import and export
through NPCs (Yoneda et al., 1987; Dargemont and Kühn,
1992). Moreover, the nuclei retain their normal diffusional
permeability barrier and can simultaneously import pro-
teins containing NLSs.
Reimport of the GFP–NFAT into the nucleus during
the export assay, which would substantially hinder quanti-
tative analysis of nuclear export, does not seem to occur in
our system to any significant level. This is because GFP–
NFAT becomes partially rephosphorylated during the ex-
port assay in a manner that apparently inactivates its NLSs
and traps it outside the nucleus. The activity of cal-
cineurin, the calcium-dependent protein phosphatase that
is responsible for NFAT dephosphorylation, is likely to be
inhibited by the EGTA present in our assay buffer. Con-
sistent with this possibility is our observation that cy-
closporin A, which inhibits the activity of calcineurin in
vivo (Flanagan et al., 1991; Liu et al., 1991), has no further
stimulatory effect on nuclear export of GFP–NFAT in vitro.
Effects of the GTPase Ran on Nuclear Export
Moroianu and Blobel (1995) previously found that a pro-
tein containing a classic NLS was released from the nu-
cleus of permeabilized cells in a Ran-stimulated fashion.
The meaning of these results is not entirely clear, because
the presence of a basic type NLS does not appear to spec-
ify shuttling between the nucleus and cytoplasm in vivo af-
ter nuclear import (Michael et al., 1995). The GFP–NFAT
that we have used as a nuclear export substrate in these
studies is a nucleocytoplasmic shuttling protein with a
well-characterized NES, and thus serves as a good model
for in vitro nuclear export studies.
Our results clearly demonstrate that the GTPase Ran is
required for nuclear export of GFP–NFAT in vitro. When
in vitro nuclear export of GFP–NFAT is analyzed in per-
meabilized cells that have not been subjected to a 308C
preincubation step, Ran alone stimulates the nuclear ex-
port of GFP–NFAT to the level achieved with cytosol.
Analysis of the effects of Ran mutants in this assay suggest
that Ran stimulates nuclear export by two different mech-
anisms that have additive effects. In the first of these
mechanisms, nuclear export is stimulated by RanQ69L,
which cannot hydrolyze its bound GTP, but is unaffected
by RanT24N, which is either free of nucleotides or in a
GDP-bound state. Thus, this mechanism appears to re-
quire GTP-bound Ran but not RanGTP hydrolysis. A sec-
ond mechanism through which Ran stimulates nuclear ex-
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RanGTP hydrolysis, since it is inhibited by RanQ69L. We
suggest that this requirement reflects an involvement of
Ran in the reimport of CRM1 (see below) and possibly
other export factors that are released from the nucleus
during the preincubataion. This dual effect of Ran can ex-
plain the higher stimulation of nuclear export in the ab-
sence of cytosol by wild-type Ran versus RanQ69L.
Our observation that GTP-bound Ran but not RanGTP
hydrolysis is required for (an intermediate level) of nu-
clear export of NFAT is consistent to the results of in vivo
studies indicating that nuclear export of a leucine-rich
NES substrate (Richards et al., 1997) and of various RNAs
(Izaurralde et al., 1997) requires GTP-bound Ran. This re-
quirement for RanGTP probably relates to the coopera-
tive binding of RanGTP with export substrate to export
receptors to form putative export complexes (Fornerod et al.,
1997b; Kutay et al., 1997).
CRM1 Is a Nucleocytoplasmic Shuttling Factor 
Involved in NFAT Export
With the exception of Ran, all rate-limiting factors re-
quired for efficient nuclear export of NFAT are retained
in the permeabilized cells after digitonin treatment. How-
ever, by preincubating cells at 308C in the absence of cyto-
sol, additional rate-limiting factor(s) are released, thereby
making the assay dependent on exogenous cytosol or nu-
clear extract, rather than on Ran alone. This provides the
basis for isolating these activities by biochemical fraction-
ation. We have purified a major cytosolic activity involved
in the stimulation of nuclear export in our standard export
assay, and have found that this activity corresponds to
CRM1 (Fornerod et al., 1997b; Fukuda et al., 1997; Ossa-
reh-Nazari et al., 1997; Stade et al., 1997). Stimulation of
nuclear export by purified CRM1 depends on the presence
of Ran. This requirement probably reflects a need for Ran
for the import of CRM1 into the nucleus, as well as the in-
volvement of Ran in the formation of a CRM1-RanGTP-
NFAT complex (Fornerod et al., 1997b) that can be ex-
ported from the nucleus (see above). Considered together,
our results involving fractionation and reconstitution con-
tribute strong direct evidence that CRM1 functions as a
nucleocytoplasmic shuttling receptor for nuclear export of
NFAT, and complements the results of earlier in vivo
studies involving temperature-sensitive mutants (Fukuda
et al., 1997; Stade et al., 1997) and overexpression of
CRM1 (Fornerod et al., 1997b). The ability to reconstitute
nuclear export in this assay with CRM1 and Ran will allow
a detailed structure-function analysis of these components.
We believe that it will be possible to identify additional
factors that regulate NFAT export using this assay. In-
deed, we have partially purified a potent activity from cy-
tosol that inhibits NFAT export in permeabilized cells
(our unpublished observations). Additional positively act-
ing export factors may be revealed under different prein-
cubation and assay conditions.
Nuclear Export Factors for NFAT Enter the Nucleus by 
a Nonconventional Import Pathway
Shuttling nuclear export factors like CRM1 have to reen-
ter the nucleus after one round of export. The strong inhi-
bition of nuclear export by RanQ69L in our standard, cy-
tosol-dependent export assay indicates that these factors
are imported into the nucleus by a Ran-dependent trans-
port pathway. Whereas importin b and transportin can be
imported into the nucleus when added to permeabilized
cells in the absence of Ran (Kose et al., 1997; Nakielny and
Dreyfuss, 1997), we consider it very likely that the nuclear
import of these proteins under more physiological condi-
tions (i.e., in the presence of cytosol and Ran) involves
RanGTP hydrolysis, since they both strongly bind RanGTP
and their import (and that of their cargos) is efficiently in-
hibited by RanQ69L and nonhydrolyzable GTP analogues
(Melchior and Gerace, 1995; Bonifaci et al., 1997; Izarraulde
et al., 1997).
We determined that neither the importin b nor trans-
portin pathways are involved in the import of export fac-
tors (including CRM1) for NFAT in our assay because
inhibiting these pathways with an excess of competing im-
port substrates or with a monoclonal antibody against im-
portin b does not diminish nuclear export of GFP–NFAT.
Taken together, our results indicate that the recycling of
nuclear export factors for NFAT involves a nonconven-
tional nuclear import pathway. If this pathway were selec-
tive for shuttling export factors, it would provide a means
to regulate nuclear export in a manner that is independent
of the nuclear protein import pathways used to transport
the bulk of nuclear proteins. Furthermore, this would al-
low the recycling of nuclear export factors without compe-
tition by other major import substrates. Understanding the
ability of the NPC to accommodate multiple different sig-
naling pathways for import as well as for export represents
an important future challenge.
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